Skip to main content

Table 2 COH parameters and embryologic data

From: Pregnancy is influenced by more than just embryo ploidy: a retrospective study on preimplantation genetic testing

 

Pregnancy

N = 77

Mean ± SD or N (%)

Nonpregnancy

N = 36

Mean ± SD or N (%)

P-value

Ovarian stimulation protocol

0.256

Long-acting GnRH-a protocol

16 (20.8%)

11 (30.6%)

 

GnRH-ant protocol

61 (79.2%)

25 (69.4%)

 

Days of gonadotropins used

10.4 ± 1.8

10.5 ± 1.9

0.804

Gonadotropin cumulative dose (IU)

2520.3 ± 769.5

2720.1 ± 658.1

0.183

FSH on day of trigger (mIU/ml)

12.6 ± 4.8

15.0 ± 5.2

0.14

LH on day of trigger (mIU/ml)

1.8 ± 1.8

1.6 ± 1.5

0.608

E2 on day of trigger (pg/ml)

3958.7 ± 1162.7

3382.1 ± 1309.5

0.025

P on day of trigger (ng/ml)

1.4 ± 1.0

1.0 ± 0.6

0.011

Oocytes retrieved

16.8 ± 6.8

12.9 ± 5.2

0.004

MII oocytes

14.4 ± 6.5

10.6 ± 4.9

0.001

2PN zygotes

12.9 ± 6.3

9.5 ± 4.6

0.001

Blastocysts

8.5 ± 4.8

6.3 ± 3.8

0.017

Euploid embryos

2.5 ± 1.4

2.4 ± 1.4

0.693

  1. GnRH-a, gonadotropin-releasing hormone agonist; GnRH-ant, gonadotropin-releasing hormone antagonist; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2 estradiol; P, progesterone; MII, metaphase II; 2PN, two pronuclei; SD, standard deviation